Form 8-K - Current report:
SEC Accession No. 0001558370-22-018383
Filing Date
2022-12-06
Accepted
2022-12-06 06:41:38
Documents
15
Period of Report
2022-12-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20221206x8k.htm   iXBRL 8-K 35036
2 EX-99.1 edit-20221206xex99d1.htm EX-99.1 24085
3 GRAPHIC edit-20221206xex99d1001.jpg GRAPHIC 5856
  Complete submission text file 0001558370-22-018383.txt   276429

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20221206.xsd EX-101.SCH 3270
5 EX-101.LAB edit-20221206_lab.xml EX-101.LAB 634
6 EX-101.PRE edit-20221206_pre.xml EX-101.PRE 10179
9 EXTRACTED XBRL INSTANCE DOCUMENT edit-20221206x8k_htm.xml XML 4672
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 221446663
SIC: 2836 Biological Products, (No Diagnostic Substances)